Physician profile
Suchitra Kavety
NPI 1730179037
$6,440.70
in general payments reported to CMS, 2019-2025
24 companies · $3,283 in 2025
The $3,283 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $280 · 2021: $162 · 2022: $98.41 · 2023: $363 · 2024: $2,152 · 2025: $3,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $943 · Travel and Lodging: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $942.77 |
| Travel and Lodging | $354.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,997.02 | 2024-2025 | |
| Abbvie INC. | $397.83 | 2019-2025 | |
| Boston Scientific Corporation | $214.35 | 2020-2025 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $130.23 | 2019-2025 | |
| Minerva Surgical, INC | $108.48 | 2020 | |
| Sumitomo Pharma America, INC. | $108.07 | 2023-2025 | Myfembree |
| Biogen, INC. | $88.95 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $71.92 | 2019-2024 | |
| Hologic Sales and Service, LLC | $40.73 | 2023-2025 | Aptima, Coolseal Generator, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $33.49 | 2023-2025 | |
| Coopersurgical, INC. | $32.92 | 2019-2025 | Paragard T 380a |
| Allergan, INC. | $23.94 | 2019-2020 | |
| Astellas Pharma US INC | $21.99 | 2025 | Veozah |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2023 | Exparel |
| Alnylam Pharmaceuticals INC. | $20.84 | 2025 | Amvuttra |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $18.46 | 2020 | |
| Meditrina | $15.93 | 2021 | |
| Sage Therapeutics, LLC | $15.53 | 2019 | |
| Amgen INC. | $14.38 | 2024 | Evenity, Prolia |
| Axonics, INC. | $13.68 | 2023 | Bulkamid, Axonics |
| Organon LLC | $13.16 | 2022 | |
| Millicent US INC | $13.10 | 2020 | |
| Mission Pharmacal Company | $12.30 | 2019 | |
| Lupin INC. | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suchitra Kavety listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.